free web stats
Category

Glioblastoma (“GBM”)

VBI Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

By | Conferences, Glioblastoma ("GBM"), Press Releases
VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) today will present new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer immunotherapy program at the Keystone Symposia Cancer Vaccines Conference taking place in Whistler, British Columbia, Canada. Keystone Symposia are peer-reviewed conferences that...
Read More

VBI Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology

By | Glioblastoma ("GBM"), Press Releases
VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) today presented an update and new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer immunotherapy program at the European Society for Medical Oncology (“ESMO”) Immuno-Oncology Symposium. During the poster presentation, Therapeutic Vaccination against...
Read More